United Therapeutics
UTHR
UTHR
319 hedge funds and large institutions have $6.8B invested in United Therapeutics in 2014 Q3 according to their latest regulatory filings, with 53 funds opening new positions, 92 increasing their positions, 145 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
319
Holders Change
+16
Holders Change %
+5.28%
% of All Funds
9.26%
Holding in Top 10
18
Holding in Top 10 Change
+14
Holding in Top 10 Change %
+350%
% of All Funds
0.52%
New
53
Increased
92
Reduced
145
Closed
36
Calls
$92.8M
Puts
$331M
Net Calls
-$238M
Net Calls Change
-$244M
Top Buyers
| 1 |
SCM
Scopia Capital Management
New York
|
+$261M |
| 2 |
AC
Amici Capital
New York
|
+$121M |
| 3 |
Millennium Management
New York
|
+$104M |
| 4 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$99.5M |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$74.7M |
Top Sellers
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$96.5M |
| 2 |
JPMorgan Chase & Co
New York
|
-$62.5M |
| 3 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$54.9M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$50.7M |
| 5 |
GAM
Gotham Asset Management
New York
|
-$46M |
